Search research articles

Search research articles

Related Experiment Videos

MR contrast agents: an overview.

¹Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia.

Radiologic Clinics of North America

|September 1, 1988

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.

Investigative radiology·1996

Same author

Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.

Investigative radiology·1996

Same author

Pseudotumor cerebri: CT findings and correlation with vision loss.

AJR. American journal of roentgenology·1993

Same author

Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides.

Investigative radiology·1990

Same author

Reversal of white matter edema in hypertensive encephalopathy.

AJNR. American journal of neuroradiology·1989

Same author

Cross-linked DTPA polysaccharides for magnetic resonance imaging. Synthesis and relaxation properties.

Investigative radiology·1989

Same journal

Orbital Imaging.

Radiologic clinics of North America·2026

Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026

Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026

Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026

Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026

Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

This article reviews magnetic resonance (MR) contrast agents, explaining how paramagnetic and superparamagnetic substances affect T1 and T2 relaxation times for enhanced medical imaging.

Area of Science:

Medical Imaging
Biophysics

Background:

Magnetic Resonance (MR) imaging relies on the relaxation properties of water protons.
Contrast agents are crucial for improving lesion detection and characterization in MR imaging.

Purpose of the Study:

To provide a comprehensive overview of current and potential MR contrast agents.
To explore the mechanisms of action and impact of contrast agents on T1 and T2 relaxation.

Main Methods:

Review of paramagnetic and superparamagnetic substances.
Consideration of various physical states: small ionic, lipophilic, and macromolecular forms.
Analysis of the relationship between contrast agents and MR relaxation processes (T1 and T2).

Main Results:

Related Experiment Videos

Paramagnetic and superparamagnetic agents function by altering local magnetic fields, affecting proton relaxation times.

Different physical forms (ionic, lipophilic, macromolecular) offer distinct biodistribution and pharmacokinetic profiles.

Clinical examples demonstrate the utility of current MR contrast agents.

Conclusions:

MR contrast agents are essential tools in diagnostic imaging.
Future developments may involve novel agents with improved efficacy, safety, and targeted delivery.
Understanding relaxation mechanisms is key to designing advanced contrast agents.